Mass General Hospital

Harvard Medical School

Tag Archives | perinatal depression

How Can We Screen for Perinatal Depression in the Developing World?

While perinatal mood and anxiety disorders (PMAD) have a global footprint, the majority of research related to this group of illnesses has come largely from more affluent, Westernized countries.  Similarly, the tools used to detect and screen for PMADs were developed and tested in these Westernized countries.   The instrument most commonly used to detect […]

Continue Reading · 1

Improving Access to Mental Health Services: Could Lay Counselors Be Used to Treat Perinatal Depression?

About 15% of women suffer from perinatal depression — depression which emerges during pregnancy or the postpartum period; however, most women with perinatal depression do not receive any  type of treatment.  While we have made huge strides in increasing awareness of postpartum mental health issues, there are still significant obstacles to obtaining treatment.  Especially in […]

Continue Reading · 1

Is BDNF a Biomarker for Depression During Pregnancy and the Postpartum Period?

Brain-derived neurotrophic factor (BDNF) is a growth factor which acts on neurons in both the central and peripheral nervous systems, promoting the survival of neurons and promoting the growth and differentiation of new neurons and synapses.  In the brain, it is most active in the hippocampus, cortex, and basal forebrain—areas important  to learning, memory, and […]

Continue Reading · 0
Credit: Pregnant Woman from Wikimedia Commons

The 50-year Quest for Better Pregnancy Data

The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: November 1, 2016 By: Gerald G. Briggs, BPharm, FCCP, Christina Chambers, PhD, MPH, Lee S. Cohen, MD, & Gideon Koren, MD Editor’s note: As Ob.Gyn. News celebrates its 50th anniversary, we wanted to know how far the medical community has come in identifying and […]

Continue Reading · 0

Study Links Conflict with Partner to Increased Vulnerability to Perinatal Depression

The Maternity Experiences Survey (MES) is a national survey of Canadian women’s experiences, perceptions, knowledge and practices before conception and during pregnancy, birth and the early months of parenthood. This is a project funded by the Public Health Agency of Canada’s Canadian Perinatal Surveillance System, with the goal of achieving a better understanding of the […]

Continue Reading · 0

New Legislation to Support Maternal Mental Health

Some good news for women with perinatal mood and anxiety disorders… Today, the U.S. House of Representatives passed the Bringing Postpartum Depression Out of the Shadows Act  to provide federal grants to develop and maintain programs for screening and treatment of postpartum depression. This bill, introduced by Congresswoman Katherine Clark (D-Mass) and Congressman Ryan Costello […]

Continue Reading · 0

Postpartum Depression and Its Effects on Children’s IQ

The research of Lynne Murray and Peter Cooper in the 1990s was pivotal in terms of demonstrating the negative effects of postpartum depression on the cognitive development of young children and played an important role in drawing attention to the often overlooked but prevalent problem of postpartum depression.  While some studies have documented that, in […]

Continue Reading · 0

Weekly Roundup for NOV 4 2016: Recent Publications in Women’s Mental Health

The first article on the list is one that relies on the Swedish medical registers to look neonatal outcomes in infants prenatally exposed to antidepressants.  While the study does not generate new things to worry about, it is one of the largest studies in this area and gives us more information on the prevalence of […]

Continue Reading · 0

Postpartum Depression: Focus on Managing Comorbid Anxiety Symptoms

  Multiple studies have demonstrated the effectiveness of antidepressant medications for the treatment of postpartum depression (PPD).  Most of the these studies focused on the impact of these medications on depressive symptoms; however, it is clear that many, or maybe most, women with PPD also have significant anxiety symptoms.  Thus, we can hypothesize that medications […]

Continue Reading · 0